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Background Proper understanding of the roles of, and interactions between gen-
etic, lifestyle, environmental and psycho-social factors in determin-
ing the risk of development and/or progression of chronic diseases
requires access to very large high-quality databases. Because of the
financial, technical and time burdens related to developing and
maintaining very large studies, the scientific community is increas-
ingly synthesizing data from multiple studies to construct large
databases. However, the data items collected by individual studies
must be inferentially equivalent to be meaningfully synthesized.
The DataSchema and Harmonization Platform for Epidemiological
Research (DataSHaPER; http://www.datashaper.org) was developed
to enable the rigorous assessment of the inferential equivalence,
i.e. the potential for harmonization, of selected information from
individual studies.
Methods This article examines the value of using the DataSHaPER for retro-
spective harmonization of established studies. Using the
DataSHaPER approach, the potential to generate 148 harmonized
variables from the questionnaires and physical measures collected
in 53 large population-based studies (6.9 million participants) was
assessed. Variable and study characteristics that might influence the
potential for data synthesis were also explored.
Results Out of all assessment items evaluated (148 variables for each of the
53 studies), 38% could be harmonized. Certain characteristics of
variables (i.e. relative importance, individual targeted, reference
period) and of studies (i.e. observational units, data collection
start date and mode of questionnaire administration) were
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associated with the potential for harmonization. For example, for
variables deemed to be essential, 62% of assessment items paired
could be harmonized.
Conclusion The current article shows that the DataSHaPER provides an effect-
ive and flexible approach for the retrospective harmonization of
information across studies. To implement data synthesis, some add-
itional scientific, ethico-legal and technical considerations must be
addressed. The success of the DataSHaPER as a harmonization ap-
proach will depend on its continuing development and on the
rigour and extent of its use. The DataSHaPER has the potential to
take us closer to a truly collaborative epidemiology and offers the
promise of enhanced research potential generated through synthe-
sized databases.
Keywords Data synthesis, data quality, data pooling, harmonization, meta-
analysis, DataSHaPER, retrospective harmonization
Introduction
In order to properly understand the role of, and inter-
action among genetic, lifestyle, environmental and
social factors in modulating the risk of development
and/or progression of chronic diseases, it is critical
that analyses have adequate statistical power.1,2
Moreover, the aetiological relations of interest are
generally complex and the risks targeted often rela-
tively weak.1,3 Scientific progress thus demands access
to very large databases4 providing comprehensive,
valid and precise information on a variety of factors
and disease traits.5 Due to the financial, technical and
time burdens related to developing and maintaining
very large studies, the scientific community is increas-
ingly making use of the synthesis of data to address
the limitations of statistical power of individual stu-
dies.6 In turn, however, when an analysis is to be
undertaken based on individual-level data integrated
between studies, the key data items assessed in indi-
vidual studies (e.g. specific measurements or ques-
tions) must not only be measured well, but the
information they convey must also be rendered ‘infer-
entially equivalent’ (or ‘harmonized’).7 A fundamen-
tal tension therefore lies between increasing sample
sizes by synthesizing data from many individual stu-
dies, and restriction of the data synthesis to those
studies that are satisfactorily harmonized and which
provide a common set of scientifically valid
information.
Given the quantity and complexity of the informa-
tion generally collected by individual established stu-
dies and the heterogeneity of their designs and
procedures, it is essential to have access to effective
methods and tools to formally explore the potential to
generate high-quality synthesized databases. Such
tools need to provide comprehensive information on:
(i) the specific variables that could be shared; (ii) the
studies that could participate in targeted analysis; and
(iii) the factors that could influence the potential to
integrate information. The DataSchema and
Harmonization Platform for Epidemiological
Research (DataSHaPER; www.datashaper.org) may
be used to provides such information.7 It includes
two primary components. The DataSchema8 docu-
ments and annotates sets of core variables, which
each provides a concise but effective list of informa-
tion to be harmonized in a specific scientific context.
The Harmonization Platform then provides a template
for the formal estimation of the potential to synthe-
size information across networks of studies. In collab-
oration with other Public Population Project in
Genomics (P3G) partner teams9–12 and projects,13,14
developments are currently ongoing to build a suite
of tools supporting all steps of individual data har-
monization, synthesis and analysis.
The current article evaluates the value of the
DataSHaPER as a foundation for retrospective har-
monization. It focuses on the Generic DataSchema
that is composed of variables aimed at supporting
the construction of general purpose baseline question-
naires and physical measures for use in large
population-based studies enrolling adult participants.7
The specific aim of the article is to investigate and
quantify the potential for harmonizing variables that
make up the Generic DataSchema questionnaires and
physical measures modules7 across more than 50 of
the world’s largest population-based studies. The art-
icle also investigates factors that might influence the
potential for harmonization, particularly the basic
study design and nature of individual variables, as
well as evaluating the utility of the Generic
DataSchema as a platform for harmonization of exist-
ing databases. The article will help guide future de-
velopment of the DataSHaPER project.
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Development of the Generic DataSchema has been
centred on a series of international consensus work-
shops bringing together experts from more than
25 studies and 14 countries. Its construction was
based upon iterative review and consensus methodol-
ogies15,16 aimed at synthesizing knowledge and input
from practitioners and researchers with a variety of
professional expertise. The primary objective was to
generate a select list of core variables that would pro-
vide a valuable contribution to the baseline interviews
of population-based studies enrolling adult partici-
pants and provide a basis for harmonization. Agreed
selection criteria were defined and used, first, to select
broad domains and, then, specific variables.7 Where
possible, variables were chosen and defined so as to
be compatible with widely used international classifi-
cation systems or standards.17–19 Over a 3-year period,
iterative rounds of discussion and comment contrib-
uted to gradual refinement of the Generic
DataSchema. In particular, a number of cohorts pro-
vided critical feedback based on their own use of early
versions of the DataSchema as a foundation for ques-
tionnaire development. These included Lifelines20
(The Netherlands), LifeGene21 (Sweden), the five co-
horts in the Canadian Partnership for Tomorrow
Project14 and the Canadian Longitudinal Study on
Aging.22 The Generic DataSchema remains a dynam-
ically evolving tool that is improving incrementally
over time based on users’ feedback and increasing
scientific knowledge.7
The ontology of the Generic DataSchema has a hier-
archical structure in which the selected variables (the
fundamental units of a statistical analysis, such as:
lifetime occurrence of cancer; highest level of educa-
tion; diastolic blood pressure) are grouped under do-
mains (e.g. individual history of cancer, education
level, blood pressure) that are themselves distributed
across themes (e.g. individual history of disease,
socio-economic status, body function measures) and
modules (health and risk factor questionnaire, phys-
ical and cognitive measures and interview administra-
tion).7 Only the health and risk factor questionnaire
and the physical and cognitive measures modules
were considered for harmonization. Basic interview
administration information (e.g. date of birth, date
of interview, sex, language and location of interview)
was collected by participating studies but not neces-
sarily through collection modes targeted by the cur-
rent exercise. Hence, even though all studies could
share constructs derived from these data (such as
age), this module was excluded from the current har-
monization exercise. Within the physical and cogni-
tive measures module, contraindications to having a
particular measurement were also excluded from the
harmonization process, since we did not have access
to consistent information on the specific contraindi-
cations targeted by studies.
Selected variable characteristics that might influence
the potential for data synthesis were documented.
These include: (i) its importance for broad-based re-
search projects as perceived by expert consensus (es-
sential, important, useful information), (ii) the
individual targeted by the variable (the participant
himself/herself, the participant’s family members)
and (iii) the period of the participant’s life to which
the variable refers (current status at assessment, all
other periods). Classification of the perceived ‘import-
ance of variables’ was based on their relevance to be
part of a generic set of information useful for a broad
range of research questions. Since this classification
was subjective, it was undertaken by two separate
experts followed by comparison, and final confirm-
ation by a panel. As an illustrative example, the fol-
lowing variables were classified as: ‘essential’:
occurrence of cancer (participant); ‘important’: occur-
rence of cancer in the family; ‘useful’: occurrence of
cancer in siblings.
Selection of participating studies
Potential studies to be included in the harmonization
process were identified using P3G’s collaborative net-
work and Study catalogue (www.p3gobservatory.org).
Eligible studies were those that had: (i) recruited or
planned to recruit at least 10 000 adult participants;
(ii) collected biological samples enabling DNA extrac-
tion; (iii) collected comprehensive information on life
habits, socio-economic status and health outcomes;
and (iv) provided access to the baseline questionnaire
and standard operating procedures used. Priority was
given to studies with the largest number of partici-
pants, those that were initiated most recently and
those that had questionnaires available in English or
French. A total of 87 studies were initially ap-
proached. Of these, 53 agreed to participate; 6
declined and 28 did not respond to our contacts.
Key characteristics were documented in order to
identify study-related factors that might influence
the potential for synthesis. These were: (i) study
design (cohort or cross-sectional); (ii) breadth of sci-
entific focus (broad scientific focus or focus on spe-
cific outcomes or exposures); (iii) source of
population sample (general population or specific sub-
population such as clinic out-patients, professional as-
sociation, etc.); (iv) participation history (new
participant or participant selected from a pre-existing
study); (v) observational units (individuals or
families); (vi) sex (whether one sex only or both
sexes were included); (vii) region of residence of the
participants (Europe, North America or other); (viii)
lower limit of participants’ age at recruitment (<25,
25–40 or 440 years); (ix) data collection start date
(before or in 2000 or after 2000), (x) targeted
number of participants (less than 100 000 or 100 000
or more); (xi) proportion of participants from whom
biological samples were collected (a subsample or all
participants); (xii) mode of administration of the
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questionnaire (computer based, paper based or
mixed); and (xiii) site of administration of the ques-
tionnaire (participant residence, clinic/assessment
centre or mixed).
Harmonization process
Using the 53 participating studies, an initial evalu-
ation was undertaken in order to determine if the
selected Generic DataSchema domains correspond to
risk factors and outcomes most frequently collected in
current practice. This was done using the keyword
tree of the P3G questionnaire catalogue, which pro-
vides a comprehensive overview of the areas of infor-
mation collected by large epidemiologic studies.23
Each DataSchema domain was attributed a corres-
ponding keyword of the keyword tree [e.g.
‘DataSchema domain’, Individual history of Cancer;
‘Keyword’, Individual History of Neoplasm—
International Classification of Diseases (ICD)]. The
proportion of the 53 participating studies collecting
information on each keyword (i.e. coverage) was
determined. This then allowed examination of the
extent to which areas of information that were se-
lected to be part of the Generic DataSchema (i.e. key-
words corresponding to DataSchema domains), or
not selected (i.e. keywords not included in
the DataSchema), were used in current practice. The
result of this analysis will help to optimize the
Generic DataSchema by adding or deleting specific
domains of interest based on their coverage among
the world’s leading population-based studies.
As the primary harmonization exercise, the potential
for each study to generate each variable included in
the Generic DataSchema was evaluated. Once specific
definitions have been attributed to each variable, the
harmonization approach entails using a three-level
scale to document the compatibility between the in-
formation generated by the assessment items of each
participating study (e.g. specific questions) and each
variable defined in the DataSchema. This process is
referred to as ‘pairing’ (Box 1).7 In order to classify
the assessment items and to ensure the validity and
reproducibility of the pairing results, sets of compre-
hensive ‘pairing rules’ specific to each variable are
defined.7 Development of pairing rules is context spe-
cific and involves a systematic process of iteration be-
tween scientific experts and trained research officers.
Using these pairing rules, trained research officers de-
termine whether or not a variable can be recreated
using the assessment items collected by each partici-
pating study. In order to ensure quality control, an
evaluator verified a random sample of 10% of all
pairing results. Whenever a pairing error was de-
tected, a consensus panel determined the final pairing
result.
Statistical methods
The chi-square statistic was used to test for difference
between the characteristics of participating and
non-participating studies. Study and variable charac-
teristics were documented using descriptive statistics
for binary and nominal variables including tabulation
and reporting of counts and percentages. Coverage of
areas of information that had been selected or not
selected to be part of the Generic DataSchema were
compared using the non-parametric Wilcoxon rank
sum test.24 Cohen’s k statistic25 was used to evaluate
agreement between the research officers conducting
the initial pairing and the final validated results.
Primary analysis was based on the standard un-
weighted k statistic25 but, because the classification
categories were ordered, two alternatively weighted
k statistics26 were also used.
Analysis of the study- and variable-level character-
istics that systematically influence the likelihood that
a given variable can be created from the assessment
Box 1 Classification of the level of compatibility between assessment items and DataSchema variables. (For a detailed
example, please refer to Fortier et al.7)
Classa Description
Complete According to the pairing rules, the meaning, format and standard operating procedures used for collection
of the assessment items allow construction of the variable as defined.
Partial According to the pairing rules, the meaning, format and standard operating procedures used for collection
of the assessment items allow the construction of the variable as defined, but with an unavoidable loss
of information. This class includes two subcategories:
‘Proximate’—when the only reason for the classification as partial is because categories are used to collect
information for a DataSchema variable that is defined as continuous.
‘Tentative’—whenever a variable is classified as partial for any other reason.
Impossible When no relevant information is collected (impossible not covered) or, based on the pairing rules,
insufficient information exists to construct the variable as defined (impossible covered).
aIn certain instances, a DataSchema variable is not pertinent in the context of a particular study (e.g. the ‘Occurrence prostate
cancer’ variable in the context of a study recruiting only women). In such cases, the variable is classified as ‘Not applicable’ for
that study.
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items of a given study was undertaken. This analysis
was used to identify factors that influence potential
for data synthesis and was based upon a type 1 gen-
eralized estimating equations (GEE) analysis,27,28
which takes appropriate account of the correlation
of variables within studies. The analysis was based
on a logistic regression model with an exchangeable




Among the 87 studies contacted, no association was
observed between study size or region of origin and
the likelihood of participation in the initiative.
However, studies that launched recruitment of partici-
pants after 2000 were more likely to respond to our
call to participate [P< 0.05, odds ratio (OR)¼ 2.73,
95% confidence interval (CI)¼ 1.11–6.71]. Fifty-three
studies accepted to participate, encompassing 6.9 mil-
lion participants, recruited or to be recruited. Of the
participating studies (Supplementary Data available at
IJE online), 48 are designated as cohorts and 5 had
cross-sectional designs. Most studies had a broad sci-
entific focus (42 studies), enrolled new participants
(46 studies), had the individual—rather than
family—as the unit of observation (47 studies) and
included both sexes (46 studies). Participants were
recruited from the general population in most studies
(44 studies). However, some (nine studies) targeted
population subgroups such as professional associ-
ations, clinic out-patients and at-risk individuals (ex-
posure or disease). The start dates for collection of
information range from the mid-1980s to 2010. Five
studies began collecting information in 1990 or before
and 18, 10 and 20, respectively, in 1991–2000,
2001–05 and 2006–10. Study sizes range from 10 000
to over half a million participants. Eight have already
recruited, or aim to recruit, 500 000 participants or
more, whereas the majority (28 studies) have a par-
ticipant recruitment target of 50 000 or less. Thirty
studies have collected or plan to collect biological
samples from all participants, whereas the others col-
lect samples from a subgroup of participants only.
A total of 26 studies recruit participants from
Europe, 17 from North America, 5 from Asia and 5
from Australia. Different data collection modes are
also used. For example, 24 studies are using paper-
based questionnaires and 13 used computer-based




In order to confirm that the Generic DataSchema does
provide effective coverage of areas of interest to a
general purpose population-based study, and in
order to assess its use in actual current practice, all
53 participating studies were keyword coded. The key-
words themselves were categorized into those that do
correspond to a Generic DataSchema domain and
those that do not. The proportion of studies that cov-
ered each keyword was then calculated and plotted
(Figure 1). Keywords that do correspond to
DataSchema domains are covered, on average, by
75.9% of studies, whereas keywords that do not are
covered by 25%. The mean difference of coverage was
therefore estimated at 50.9% (P< 0.00001, 95%
CI¼ 42.2–59.2). Furthermore, all keywords covered
by at least 78% of participating studies correspond
to DataSchema domains (Figure 1). However, even
if the DataSchema includes areas generally used in
current practice, a few exceptions are noted. For ex-
ample, the ‘Subject family’s birth location’ keyword is
included in the DataSchema, but is only covered by
34% of the studies. Similarly, ‘Familial diseases of the
respiratory system’ and ‘Familial mental and behav-
ioural disorders’ (ICD10) keywords are also in the
DataSchema, but only covered by 36 and 38% of the
studies, respectively. On the other hand, ‘Individual
disease of the genitourinary system’ (ICD10) and
‘Individual disease of the digestive system’ (ICD10)
are covered, respectively, by 75 and 77% of the stu-
dies, but are not included in the DataSchema.
Variables
All 148 Generic DataSchema variables encompassed
by the questionnaire and physical measures modules
were included in the pairing exercise. Among the vari-
ables paired, 38 were classified as ‘essential’ for broad
focused epidemiological research, 45 were considered
‘important’ and 65 were deemed ‘useful’. A total of
101 variables (68%) target information directly related
to the participant (e.g. Occurrence of menopause,
Height), whereas 47 (32%) target the participant’s
family (e.g. Occurrence of diabetes in siblings).
Forty variables (27%) target information related to
the time at which the assessment took place (e.g.
Current smoking status), whereas the remaining 108
variables target information relating to other time
periods in the participant’s life (e.g. Age at first
pregnancy).
Harmonization results
The overall pairing process shows that 36% of all as-
sessment items paired (148 variables paired for each
of the 53 studies) were classified as ‘Complete’, 3% as
‘Partial Proximate’, 14% as ‘Partial Tentative’, 47% as
‘Impossible’ (7.2% ‘Impossible Covered’ and 40.2%
‘Impossible Not Covered) and 0.2% as ‘Not
Applicable’. See Box 1 for definitions of pairing clas-
sifications. Some continuous variables, defined as
open-ended in the Generic DataSchema, simultan-
eously show a very low proportion of ‘Complete’
matches and a relatively high percentage of ‘Partial
Proximate’ matches (e.g. Household income—4%
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‘Complete’ matches and 47% ‘Partial Proximate’
matches). Although such variables stray from the
ideal ‘Complete’ match because of the use of categor-
ical responses in study questionnaires, they can none-
theless be synthesized across studies with a minor
loss of information. In the following results, ‘Partial
Proximate’ matches are grouped with ‘Complete’
matches. Across the 53 studies, the proportion of
combined ‘Complete’ and ‘Partial Proximate’ pairings
ranged from a minimum of 20% (29 out of 148 vari-
ables) up to a maximum of 90% (133 out of 148 vari-
ables) per individual study. Conversely, the variation
across the DataSchema variables ranged between 4%
(2 of 53 studies) and 89% (47 of 53 studies). For 35
variables, at least 60% of the participating studies
provided a ‘Complete/Partial Proximate’ match
(Table 1 for examples of ‘well-paired’ variables, i.e.
65% or more). On the other hand, for 12 of the 148
variables (e.g. Heaviest ever alcohol consumption,
Occurrence of chronic obstructive pulmonary disease
in the family, Town of birth), at least 80% of the
participating studies provided an ‘Impossible not cov-
ered’ match, meaning these variables were in fact not
examined by the majority of participating studies.
Complete pairing results of all Generic DataSchema
variables are included in Supplementary materials
(Supplementary Data available at IJE online).
Figure 1 Percentage of studies covering keywords included and not included in the Generic DataSchema. Example of
keywords not included in the Generic DataSchema (percentage of studies covering): (a) Certain conditions originating in
the perinatal period (2%); (b) Language (21%) and (c) Certain infectious and parasitic diseases (42%). Example of keywords
included in the Generic DataSchema (percentage of studies covering): (d) Endocrine, nutritional and metabolic diseases
(64%); (e) Diseases of the respiratory system (83%) and (f) Tobacco use (98%)
Table 1 Pairing results (%) for selected variables presenting




Occurrence of diabetes 89
Current use of alcohol 89
Level of physical activity 85
Occurrence of high blood pressure 83
Occurrence of menopause 83
Occurrence of cancer 81
Occurrence of stroke 81
Employment status 81
Menopause onset 75
Occurrence of asthma 74
Current quantity of cigarettes smoked 74
Occurrence of myocardial infarction 72
Living with partner 68
Type of cancer 66
Standing height 66
Weight 66
*For full-pairing results, please refer to supplementary mater-
ials (Supplementary Data available at IJE online).
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Although we have deliberately chosen to present the
data in a conservative manner (so that we are not
overstating the quality of pairing), it might reasonably
be argued that evaluation of the harmonization po-
tential should sometimes be restricted to those studies
that have actually collected information related to a
particular variable of interest. That being the case,
each ‘Impossible Not Covered’ and ‘Not Applicable’
matches would be excluded from the denominator.
This increases the overall proportion of ‘Complete/
Partial Proximate’ matches to 64% and limits the
‘Impossible’ matches to those that had insufficient
information to construct the variable (‘Impossible
Covered’; 12%).
For quality control purposes, a total of 718 randomly
paired assessment items were subjected to blind re-
assessment by a validation panel (9% of all assess-
ment items paired). A total of 3.2% of the validated
pairing matches indicated a disagreement between
the original assessor and the validation panel in cate-
gorizing the pairing as ‘Complete’, ‘Partial’ or
‘Impossible’. Cohen’s k was estimated and indicated
excellent agreement between the original pairing as-
sessments and the validation panel’s reassessments
(OR¼ 0.948, 95% CI¼ 0.926–0.970). The occurence
of pairing errors was not influenced by the nature
of the variable, the research officer conducting pair-
ing, or other characteristics such as paring levels.
Since the allocation categories were ordered, a sensi-
tivity analysis using two alternatively weighted k stat-
istics was also undertaken—the results were very
similar: OR: 0.945 (95% CI: 0.923–0.967) and OR:
0.957 (95% CI: 0.939–0.975).
Study-specific pairing results
Table 2 presents the association between pairing re-
sults and study characteristics. The study’s observa-
tional units, data collection start date, proportion of
biological samples collected and mode of question-
naire administration are each associated with pairing
results in a series of univariate models. The table also
presents the variables that were associated with pair-
ing results using a multivariate model (observational
units, data collection start date and mode of question-
naire administration). When considering only the
nine studies that exhibit characteristics that typically
facilitate harmonization (i.e. those enrolling individ-
ual participants, not families; commencing after the
year 2000 and using computerized questionnaires),
the overall proportion of ‘Complete/Partial
Proximate’ matches was 50%. This proportion is
higher than the 38% seen when all 53 studies are
considered.
Variable-specific pairing results
Three variable-specific characteristics exhibited sub-
stantive association with the potential for harmoniza-
tion (Table 3): variable importance; individual
targeted by the variable; period targeted by the
variable. About 62% of pairing matches for variables
considered as collecting ‘essential’ information were
‘Complete/Partial Proximate’, compared with 43% for
variables considered ‘important’ and 22% for variables
classified as ‘useful’. For the nine studies outlined in
the section above, when only the ‘essential’ variables
are considered (38 variables), 81% of pairing matches
are either ‘Complete’ or ‘Partial Proximate’.
Case study
A case study is used to illustrate the potential scien-
tific utility of harmonization under the DataSHaPER.
It was defined during a workshop involving partici-
pating studies and explores the possibility to investi-
gate the association between blood pressure and five
risk factors: education level; body mass index; phys-
ical activity; current alcohol use and cigarette con-
sumption (Table 4). Variables were initially chosen
based on their scientific relevance, but harmonization
potential was also considered in order to finalize se-
lection. As noted earlier, although age and sex vari-
ables were not included in the formal harmonization
process, they were nonetheless available for all parti-
cipating studies and could be included as covariates in
this pooled analysis.
Based on the pairing results, 14 studies (2 million
participants) could potentially collaborate fully in a
pooled analysis of associations between blood pres-
sure and the stated factors. For the 14 studies, it is
anticipated that DNA will ultimately be collected from
a total of 1.6 million participants (1.2 million samples
have already been collected). The differences between
these 14 studies and the remaining 39 were explored.
The 14 studies differed from the rest for all charac-
teristics outlined in Table 2 with the exception of the
‘targeted number of participants’ characteristic. For
example, they all targeted individuals, all except one
began after the year 2000, and they used a computer
more frequently as the administration mode for
questionnaires.
In a second illustrative example, ‘Occurrence of dia-
betes (participant)’, ‘Occurrence of diabetes in the
family’ and ‘Body mass index’ could be successfully
recreated by 11 studies. If gene–environment inter-
actions were to be examined, biological samples are
expected to be collected from 848 000 participants in
these 11 studies.
Discussion
The current article provides an overview of the poten-
tial for the DataSHaPER approach to serve as founda-
tion for retrospective harmonization across large
population-based studies. There can be little doubt
that the overall harmonization observed seems good
enough to provide real scientific utility. However, the
potential for harmonization is influenced by the types
of variables targeted and study characteristics.
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Cohort (0) 48 36 3 14 48
Cross-sectional (1) 5 40 2 15 44 0.124 0.1384
Scientific focus
Broad scientific focus (0) 42 36 2 15 46
Focus on specific outcome or exposure (1) 11 35 3 9 53 0.048 0.243
Population sample source
General population (0) 44 38 3 14 46
Specific subpopulation (1) 9 29 3 12 57 0.369 0.2343
Participation history
New participant (0) 46 37 3 14 47
From pre-existing study (1) 7 32 2 13 53 0.230 0.1447
Observational units
Individuals (0) 47 37 3 14 46
Families (1) 6 29 2 12 57 0.358** 0.1469
Sex
One sex only (0) 7 29 5 13 54
Both sexes (1) 46 37 2 14 47 0.268 0.2895
Region of residence of the participants
Europe (1) 26 35 2 15 48
North America (2) 17 40 4 13 44 0.298 0.225
Other (3) 10 33 1 13 53 0.122 0.1572
Lower limit of age at recruitment (years)
25–40 (1) 19 38 3 15 45
<25 (2) 25 36 2 13 49 0.084 0.2075
440 (3) 9 34 3 16 48 0.172 0.2838
Data collection start date
Before or in 2000 (0) 23 27 3 14 56
After 2000 (1) 30 43 2 14 41 0.639*** 0.1464
Targeted number of participants
Less than 100000 (0) 38 36 3 14 48
More than or equal to 100000 (1) 15 37 3 14 46 0.086 0.1978
Proportion of biological samples collected
Subsample (0) 23 29 3 14 54
All participants (1) 30 41 2 14 43 0.461** 0.1589
Mode of administration of the questionnaire
Computer-based (1) 13 46 2 13 39
Paper-based (2) 24 29 2 15 54 0.711*** 0.1902
Mix (3) 16 38 3 14 45 0.271 0.2119
(continued)
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Recognition of an ‘acceptable but restricted’ level of
heterogeneity is inherent to the DataSHaPER ap-
proach. Harmonization potential would be much
lower if the use of ‘identical’ data collection proced-
ures and tools were required to synthesize data. As an
illustrative example, 16 (30%) of the participating stu-
dies used the specific wording ‘Has a doctor (or phys-
ician) ever told you that you had diabetes?’ in their
questionnaire. The flexibility provided by the
DataSHaPER approach increased the potential for har-
monization to 89% (47 studies allowed construction
of the variable ‘Occurrence of diabetes’). As an ex-
ample of flexibility, even if two distinct questions
for types 1 and 2 diabetes were used, the variable
‘Occurrence of diabetes’ could be constructed.
However, it can be hazardous to achieve harmoniza-
tion procedures without using ‘systematic-’ and
‘scientifically-based’ rules and procedures. For ex-
ample, the potential to harmonize the question ‘Has
a health professional ever told you that you have dia-
betes or high blood sugar levels?’ could be interpreted
differently by two independent investigators. In order
to ensure quality of the harmonization process and,
thus, the quality and scientific usefulness of the final
database generated, it is essential to follow rigorous
procedures and to have access to systematic and com-
prehensive information on the data collection proced-
ures adopted by the studies involved.
Although this project has helped demonstrate the
value of the DataSHaPER, some of its limitations
must be highlighted. These limitations can be related
to the: (i) variables selected and pairing rules defined;
(ii) participating studies; and (iii) harmonization pro-
cess. First, even if defined under consensus work-
shops, there is inevitably an element of subjectivity
in variable selection and pairing rules definition.
Furthermore, the Generic DataSchema was developed
in order to support the harmonization of general pur-
pose baseline questionnaires and physical measures.
The variables and pairing rules have been selected
and defined in that context. Therefore, they will not
be appropriate for ‘all’ scientific questions that could
potentially be addressed using the harmonized infor-
mation. DataSchemas developed by new research pro-
grammes could certainly make use of the variables
and rules already developed, but investigators will
have to ensure proper customization of the variables
and rules, or develop completely new DataSchemas to
reflect their specific needs. The second point refers to





















Site of administration of the questionnaires
Participant residence (1) 20 31 3 15 51
Clinic/assessment centre (2) 12 38 2 16 45 0.23 0.1742
Mix (3) 21 39 3 13 45 0.331 0.2087
Multivariate analysis
Observational units
Individuals (0) – –
Families (1) 0.401*** 0.1047
Data collection start date
Before or in 2000 (0) – –
After 2000 (1) 0.460** 0.1350
Mode of administration
Computer-based (1) – –
Paper-based (2) 0.548** 0.1797
Mix (3) 0.275 0.2056
aStructure of the analysis: complete or partial proximate vs partial tentative or impossible.
Figures quoted denote log ORs, robust standard errors and associated P-values (*significant at <0.05, **significant at <0.01,
***significant at <0.001).
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rate was observed. However, sampling was ultimately
based on a comprehensive, but finite number of stu-
dies and specific selection criteria (e.g. availability of
questionnaires in French or English). Furthermore, a
higher participation rate was observed for studies
launched after 2000. Consequently, participating stu-
dies should not be considered as representative of ‘all’
studies with similar profiles. The third point relates to
the quality of the harmonization process. A rigorous
approach has been used in order to achieve harmon-
ization. However, as the current exercise was the first
harmonization project to make use of the
DataSHaPER tools, procedures and web interfaces
were necessarily tailored as the project proceeded.
Furthermore, even though the present article formally
evaluates the harmonization potential of the
DataSHaPER, actual pooling of data was not achieved
and therefore quality of a common database cannot
be assessed. Further work is therefore underway in
order to formally validate the quality of real data
that have been synthesized using the DataSHaPER.
In addition to the integration of formal procedures
to assess the quality of synthesized databases gener-
ated, several additional developments will be required
in the near future, if we are to optimize the utility of
the DataSHaPER. For example, the current article
focuses on information collected from participants at
baseline interview, but it is essential to extend the
harmonization process to longitudinal data. The
DataSHaPER software and ontology is currently cus-
tomized to integrate repeated assessments in order to
respond to that issue. Furthermore, harmonization
was initially limited to questionnaires and physical
measures. To broaden the scope and to increase the
Table 3 Univariate and multivariate models; variable characteristics and pairing results
Number of
variables
Average across studies of


















Essential (1) 38 60 2 15 23
Important (2) 45 38 5 13 44 0.776*** 0.0932
Useful (3) 65 21 1 14 64 1.772*** 0.1239
Targeted individual
Participant (0) 101 46 3 12 39
Participant’s family members (1) 47 14 1 19 66 1.679*** 0.199
Targeted period
Current status (0) 40 50 4 11 36
All other periods (1) 108 31 2 15 52 0.841*** 0.1112
Multivariate analysis
Variable importance
Essential (1) – –
Important (2) 0.515*** 0.0859
Useful (3) 1.214*** 0.0987
Targeted individual
Participant (0) – –
Participant’s family members (1) 1.114*** 0.1883
Targeted period
Currently status (0) – –
All other periods(1) 0.245* 0.1163
aStructure of the analysis: complete or partial proximate versus partial tentative or impossible.
Figures quoted denote log odds ratios, robust standard errors and associated P-values (*significant at <0.05, **significant at <0.01,
***significant at <0.001).
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utility of the platform, the DataSHaPER is also being
customized to integrate information extracted from
additional sources, such as biospecimen repositories
(e.g. samples processing and banking conditions)
and registries (e.g. hospitalization, disease, death
registries, environmental databases).
A number of more generic challenges must also be
noted. First, important technical considerations need
to be addressed to enable data synthesis. For example,
the heterogeneity of the information management
systems (e.g. Excel spreadsheet, SQL relational data-
bases, SAS, SPSS, etc.) used by studies represents an
important obstacle. To enable synthesis, a common
data model that facilitates a consistent data represen-
tation across studies needs to be implemented in add-
ition to the application of variable transformation
rules (i.e. algorithms) that enable unit conversions
and harmonized variable construction. Restrictive
data-access policies and participant consent forms
that prevent studies from sending individual data to
third parties (e.g. a central data warehouse) also rep-
resent an important challenge for data pooling.
However, there are ways to circumvent such prob-
lems, for example, by implementing a federated data-
base network through methodological tools such as
DataSHIELD10 or using aggregated data in a
study-level meta-analysis. Nevertheless, the potential
for access to data and samples seems to be generally
good for the participating studies. A survey has been
conducted by P3G to document the access policies of
the 53 participating studies. To date, information has
been provided by 45 of the studies and all but 4
permit access to data and samples by external re-
searchers. However, whenever external access to in-
formation is permitted, limitations related to consent
and intellectual property issues, the costing structure
imposed and the time needed to navigate formal
access procedures and receive data can all represent
substantial burdens on scientists wishing to make use
of information.
The generous collaborative involvement of some of
the world’s largest and most respected population-
based studies has provided an ideal platform to
launch the DataSHaPER project and will provide in-
valuable expertise for its future development. This
first collaborative analysis will allow the improvement
of the Generic DataSchema and DataSHaPER open
source software. Updates, taking into account the
results, of the harmonization process have been
posted on the web for open access (www.datashaper.
org). The collaborative analysis also raised
the prospect of using the DataSHaPER far more
extensively and for a wide range of different scientific
purposes. We continually look to involve more
population-based studies, investigators and tool
developers in the DataSHaPER initiative and will
welcome any suggestions or new projects making
use of the platform from readers of this article.
It is only through the realization of collaborative
projects undertaking applied research using harmo-
nized data that the DataSHaPER tool will be
improved and that the exciting research potential
provided by synthesized databases can ultimately be
achieved.


















(1) Systolic blood pressure 31 studies 3 731 000 1 816 000 3 326 000
(2) Diastolic blood pressure
(1) Systolic blood pressure 28 studies 3 131 000 1 700 000 2 746 000
(2) Diastolic blood pressure
(3) Body mass index
(4) Level of physical activity
(1) Systolic blood pressure 14 studies 2 019 000 1 335 000 1 649 000
(2) Diastolic blood pressure
(3) Body mass index
(4) Level of physical activity
(5) Current use of alcohol
(6) Current quantity of cigarettes smoked
(7) Some elements of post-secondary education
aAge and sex are also collected by all studies.
1324 INTERNATIONAL JOURNAL OF EPIDEMIOLOGY







Genome Canada and Genome Quebec (The Public
Population Project in Genomics); Canadian
Partnership Against Cancer (CPT); European FP6
(LSHG-CT-2006- 518418 to Promoting
Harmonization of Epidemiological Biobanks in
Europe); Medical Research Council Project Grant
(G0601625; methods programme in genetic epide-
miology at the University of Leicester that focuses
on genetic statistics and largescale data harmoniza-
tion and pooling); Wellcome Trust Supplementary
Grant (086160/Z/08/A); National Institute for Health
Research (Leicester Biomedical Research Unit in
Cardiovascular Science); J.L. is a Canada Research
Chair in Human Genome Epidemiology.
Acknowledgements
We would like to thank all of the studies and bio-
banking experts that provided advice and information
on the development of the DataSHaPER, and are now
part of the ongoing collaboration that is taking the
DataSHaPER project forward. The funders had no
role in study design, data collection and analysis,
the decision to publish, or preparation of the
manuscript.
Supplementary Data
Supplementary Data are available at IJE online.
Conflict of interest: None declared.
References
1 Burton PR, Hansell AL, Fortier I et al. Size matters: just
how big is BIG?: Quantifying realistic sample size require-
ments for human genome epidemiology. Int J Epidemiol
2009;38:263–73.
2 Spencer CC, Su Z, Donnelly P et al. Designing
genome-wide association studies: sample size, power, im-
putation, and the choice of genotyping chip. PLoS Genet
2009;5:e1000477.
3 Hindorff LA, Sethupathy P, Junkins HA et al. Potential
etiologic and functional implications of genome-wide as-
sociation loci for human diseases and traits. Proc Natl Acad
Sci U S A 2009;106:9362–67.
4 Hunter DJ. Gene-environment interactions in human dis-
eases. Nat Rev Genet 2005;6:287–98.
5 Wong MY, Day NE, Luan JA et al. The detection of
gene-environment interaction for continuous traits:
should we deal with measurement error by bigger studies
or better measurement? Int J Epidemiol 2003;32:51–57.
6 Thompson A. Thinking big: large-scale collaborative re-
search in observational epidemiology. Eur J Epidemiol
2009;24:727–31.
7 Fortier I, Burton PR, Robson PJ et al. Quality, quantity
and harmony: the DataSHaPER approach to integrating
data across bioclinical studies. Int J Epidemiol 2010;39:
1383–89.
8 DataSHaPER. The DataSHaPER (DataSchema and
Harmonization Platform for Epidemiological Research) 2009.
http://www.datashaper.org (23 June 2011, date last
accessed).
9 OBiBa. Open Source Software for Biobanks 2010. http://www
.obiba.org/ (23 June 2011, date last accessed).
10 Wolfson M, Wallace SE, Masca N et al. DataSHIELD:
resolving a conflict in contemporary bioscience—perform-
ing a pooled analysis of individual-level data without
sharing the data. Int J Epidemiol 2010;39:1372–82.
11 Gostev M, Fernandez-Banet J, Rung J et al. SAIL – a
software system for sample and phenotype availability
across biobanks and cohorts. Bioinformatics 2011;27:
589–91.
12 Inventory.nl and The Groningen Bioinformatics Center.
MOLGENIS Project, 2010. http://www.molgenis.org/ (23
June 2011, date last accessed).
13 BioSHaRE. Biobank Standardisation and Harmonisation for
Research Excellence in the European Union 2011. http://
www.bioshare.eu/ (23 June 2011, date last accessed).
14 Borugian MJ, Robson P, Fortier I et al. The Canadian
Partnership for Tomorrow Project: building a pan-
Canadian research platform for disease prevention.
CMAJ 2010;182:1197–1201.
15 Dalkey N, Helmer O. An experimental application of the
Delphi method to the use of experts. Manage Sci 1963;9:
458–67.
16 Glaser EM. Using behavioral science strategies for
defining the state-of-the-art. J App Behav Sci 1980;16:
79–92.
17 World Health Organization. International Statistical
Classification of Diseases and Related Health Problems, 10th
Revision, Version for 2007. http://apps.who.int/classifica
tions/apps/icd/icd10online/ (23 June 2011, date last
accessed).
18 Craig CL et al. International physical activity question-
naire: 12-country reliability and validity. Med Sci Sports
Exerc 2003;35:1381–95.
19 International Labour Organization. International Standard
Classification of Occupations (ISCO), 2010. http://www.ilo
.org/public/english/bureau/stat/isco/index.htm (23 June
2011, date last accessed).
20 Stolk RP, Rosmalen JG, Postma DS et al. Universal risk
factors for multifactorial diseases: LifeLines: a
three-generation population-based study. Eur J Epidemiol
2008;23:67–74.
21 Almqvist C, Adami HO, Franks PW et al. Lifegene–a large
prospective population-based study of global relevance.
Eur J Epidemiol 2011;26:67–77.
22 Raina PS, Wolfson C, Kirkland SA et al. The Canadian
longitudinal study on aging (CLSA). Can J Aging 2009;
28:221–9.
23 Public Population Project in Genomics (P3G). P3G
Observatory - Questionnaire Keywords, 2010. http://www.
p3gobservatory.org/Observatory.html#QUESTIONNAIRE_
KEYWORDS.
24 Armitage P, Berry G. Statistical Methods in Medical Research.
3rd edn. Oxford: Blackwell Scientific Publications, 1994.
25 Garner JB. The standard error of Cohen’s Kappa. Stat Med
1991;10:767–75.
THE DATASHAPER APPROACH AND RETROSPECTIVE HARMONIZATION 1325






26 Bonnardel P. The Kappa.exe Program, 2001. http://kappa
.chez-alice.fr/Kappa_cohen.htm (23 June 2011, date last
accessed).
27 Liang K-Y, Zeger SL. Longitudinal data analysis using
generalized linear models. Biometrika 1986;73:13–22.
28 Burton P, Gurrin L, Sly P. Extending the simple linear
regression model to account for correlated responses:
an introduction to generalized estimating equations





Participating Biobanks/Studies (arranged alphabetical-
ly by biobank/study, and then alphabetically by last
name) are given below.
45 and Up Study (The): Emily Banks,1,2 Louisa
Jorm1,3; Agricultural Health Study: Laura Beane-
Freeman,4 Jane A Hoppin5; Airwave Health
Monitoring Study: Paul Elliott,6 Deepa Singh6;
Australasian Colorectal Cancer Family Study: John
Hopper,7 Australian Breast Cancer Family Study:
John Hopper7; Black Women’s Health Study: Lynn
Rosenberg,8 Julie R Palmer8; Canadian Health
Measures Survey: Gary Catlin,9 Michael Wolfson9;
Canadian Longitudinal Study on Aging: Susan
Kirkland,10 Parminder Raina,11 Christina
Wolfson12,13; Cancer Prevention Study – 3: Alpa V
Patel,14 Michael J Thun14; Cancer Prevention
Study – II Nutrition Cohort: Susan M Gapstur,14
Michael J Thun14; CARTaGENE: Claude Laberge,15;
Cohort of Swedish Men: Niclas Hakansson16 Alicja
Wolk16; Constance Project: Marcel Goldberg,17 Marie
Zins17; Canadian Partnership for Tomorrow Project:
Marilyn Borugian,18,19 Richard P Gallagher,18,19 John
McLaughlin,20 Louise Parker,21 John D Potter,22 Paula
Robson23; The General Suburban Population Study
(GESUS): Christina Ellervik24; European Prospective
Investigation into Cancer and Nutrition: Aurelio
Barricarte,25,26 Franco Berrino,27 Heiner Boeing,28
Marie-Christine Boutron-Ruault,29, 30 H Bas Bueno-
de-Mesquita,31,32 Franc¸oise Clavel-Chapelon,29,30
Miren Dorronsoro,33 Carlos A Gonzalez,34 Goran
Hallmans,35 Rudolf Kaaks,36 Kay-Tee Kaw,37 Tim J
Key,38 Eiliv Lund,39 Jonas Manjer,40 Traci Mouw,41
Carmen Navarro,42,43 Kim Overvad,44 Domenico
Palli,45 Salvatore Panico,46 Petra HM Peeters,41, 47
Elio Riboli,41 Laudina Rodriguez,48 Isabelle
Romieu,49 Maria-Jose´ Sa´nchez,43,50 Nadia Slimani,49
Anne Tjønneland,51 Antonia Trichopoulou,52, 53
Rosario Tumino,54 Paolo Vineis41, 55; Estonian
Genome Centre: Helen Alavere,56 Andres Metspalu56;
FINRISK 2002: Markus Perola57,58; Gazel Cohort
Study (The): Marcel Goldberg,17 Marie Zins17;
Generation Scotland – Scottish Family Health Study:
Pamela Linksted,59 Andrew D Morris60; Genome
Database of Latvian Population: Janis Klovins,61
Linda Tarasova61; Japan Public Health Center-based
Prospective Study – Cohort I: Manami Inoue,62
Shoichiro Tsugane62; Japan Public Health Center-
based Prospective Study – Cohort II: Manami
Inoue,62 Shoichiro Tsugane62; KORA-gen –
Cooperative health research in the Region of
Augsburg: Angela Do¨ring,63 H Erich
Wichmann64,65,66; Kadoorie Study of Chronic Disease
in China: Zhengming Chen,67 Liming Li68,69; Kaiser
Permanente Research Program on Genes,
Environment, and Health: Catherine Schaefer,70
Larry Walter70; Korean Multi-Centre Cohort I: Sue K
Park,71,72 Keun-Young Yoo71; LifeGene: Mikael
Eriksson,73 Nancy Pedersen73; LifeLines Cohort
Study and Biobank: Joost Keers,74 Bruce HR
Wolffenbuttel75; Malmo¨ Diet Cancer: Jonas
Manjer,40 Peter Nilsson76; Melbourne Collaborative
Cohort Study: Dallas R English77; Mexican-American
Cohort Study: Melissa Bondy,78 Anna Wilkinson78;
Moli-sani Project: Amalia De Curtis,79 Licia
Iacoviello79; Montreal Heart Institute Biobank:
Marie-Pierre Dube´,80 Nathalie Laplante,80 Jean-
Claude Tardif80; NIH-AARP Diet and Health Study:
Arthur Schatzkin,81 Yikyung Park81; NUgene Project:
Rex L Chisholm,82 Wendy A Wolf82; National Child
Development Study (1958 British birth cohort): Jon
Johnson83; National DNA Bank – BancoADN:
Andre´s Garcia-Montero,84 Alberto Orfao84; National
FINRISK Study 2007 (The): Markus Perola57,58;
National Health and Nutrition Examination Survey
2001-2002: Jody E McLean,85 Geraldine M
McQuillan85; National Health and Nutrition
Examination Survey III: Jody E McLean,85 Geraldine
M McQuillan85; Nord-Trøndelag Health Study (The):
Kristian Hveem86; Norwegian Women and Cancer
Study postgenome cohort: Vanessa Dumeaux,39 Eiliv
Lund39; Nutrinet-Sante´: Pilar Galan,87,88 Serge
Hercberg87; Screening Across the Lifespan Twin
Study: Patrik KE Magnusson73; Singapore
Consortium of Cohort Studies: Kee-Seng Chia,89 En
Yun Loy89; Sister Study (The): Genetic and
Environmental Risk Factors for Breast Cancer: Lisa
A DeRoo,90 Dale P Sandler90; Sweden Mamography
Cohort: Niclas Hakansson,16 Alicja Wolk16; Swedish
Twin Study of Adults: Genes and Environments
(The): Patrik KE Magnusson73; UK Biobank: a
large-scale prospective epidemiological resource: Rory
Collins,91 Tim Peakman92; UK Women’s Cohort
Study: Victoria J Burley,93 Janet Cade,93 Darren C
Greenwood93; Vitamins And Lifestyle Study: A
cohort Study of Dietary Supplements and Cancer
Risk; Carolyn M Hutter,94 Emily White94; Western
Australia Sleep Health Study: Lyle J Palmer95,96;
DataSHaPER development team: Franc¸ois
L’Heureux,97 Genevie`ve Lachance,97 Ce´dric
Thiebault,97 Anne Vilain,97 Mayss Naccache,97
Ferima Sanogo,97 E´tienne Morency-Bachand,97
Cle´ment Tamisier,97 Susan A Atkinson98 and Andrea
Rengifo,98 Myle`ne Desche`nes97
1326 INTERNATIONAL JOURNAL OF EPIDEMIOLOGY






1The Sax Institute, Sydney, Australia, 2National
Centre for Epidemiology and Population Health,
Australian National University, Canberra, Australia,
3School of Medicine, University of Western Sydney,
Campbelltown Campus, Penrith South, Australia,
4Occupational and Environmental Epidemiology
Branch, Division of Cancer Epidemiology and Genet-
ics, National Cancer Institute, National Institutes of
Health, Department of Health and Human Services,
Bethesda, MD, USA, 5Epidemiology Branch, National
Institute of Environmental Health Sciences, National
Institutes of Health, Department of Health and
Human Services, Research Triangle Park, NC, USA,
6Department of Epidemiology and Biostatistics,
School of Public Health, and MRC-HPA Centre for
Environment and Health, Imperial College London,
St Mary’s Campus, London, UK, 7Centre for Molecu-
lar, Environmental, Genetic and Analytic Epidemiol-
ogy, University of Melbourne, Melbourne, Victoria,
Australia, 8Slone Epidemiology Center, Boston Univer-
sity, Boston, MA, USA, 9Statistics Canada, Ottawa,
Ontario, Canada, 10Department of Medicine, Dalhou-
sie University, Halifax, Nova Scotia, Canada,
11Department of Clinical Epidemiology and Biostatis-
tics, Faculty of Health Sciences, McMaster University,
Hamilton, ON, Canada, 12Division of Clinical Epidem-
iology, Research Institute McGill University Health
Centre Professor, Montreal, Quebec, Canada,
13Department of Epidemiology & Biostatistics & Occu-
pational Health, and Department of Medicine, McGill
University, Montreal, Quebec, Canada, 14Department
of Epidemiology and Surveillance Research, American
Cancer Society, Atlanta, GA, USA, 15Faculty of Medi-
cine, Laval University, Que´bec, Canada, 16Institute of
Environmental Medicine, Karolinska Institutet, Stock-
holm, Sweden, 17Inserm-Versaillles Saint Quentin
University, Unite´ 1018, Hopital Paul Brousse, Villejuif,
France, 18Cancer Control Research, British Columbia
Cancer Agency, Vancouver, BC, Canada, 19Department
of Health Care and Epidemiology, University of Brit-
ish Columbia, Vancouver, BC, Canada, 20Samuel
Lunenfeld Research Institute of the Mount Sinai Hos-
pital, Toronto, ON, Canada, 21Department of Medicine
and Department of Paediatrics, Dalhousie University,
Halifax, NS, Canada, 22Canacer Prevention Program,
Division of Public Health Sciences, Fred Hutchison
Cancer Research Centre, Seattle, WA, USA, 23Popu-
lation Health Research, Alberta Health Services –
Cancer Care, Edmonton, AB, Canada, 24Department
of Clinical Biochemistry, Copenhagen University Hos-
pital, Naestved, Denmark, 25Navarre Institute Public
Health, Pamplona, Spain, 26Consortium for Biomedi-
cal Research in Epidemiology and Public Health
(CIBER Epidemiologı´a y Salud Pu´blica-CIBERESP),
Spain, 27Epidemiology and Prevention Unit, Fonda-
zione IRCCS Istituto Nazionale Tumori, Milano,
Italy, 28Department of Epidemiology, German Insti-
tute of Human Nutrition, Potsdam-Rehbruecke, Ger-
many, 29 Inserm, Centre for Research in Epidemiology
and Population Health, U1018, Institut Gustave
Roussy, F-94805, Villejuif, France, 30Paris South Uni-
versity, UMRS 1018, F-94805, Villejuif, France,
31National Institute for Public Health and the
Environment (RIVM), Bilthoven, Netherlands,
32Department of Gastroenterology and Hepatology,
University Medical Center Utrecht (UMCU), Utrecht,
The Netherlands, 33Public Health Department of
Gipuzkoa, San Sebastian, Spain, 34Unit of Nutrition,
Environment and Cancer, Catalan Institute of Oncol-
ogy, IDIBELL, Barcelona, Spain, 35Department of
Public Health and Clinical Medicine, Nutritional
Research, Umea˚ University, Umea˚, Sweden, 36Division
of Clinical Epidemiology, German Cancer Research
Center, Heidelberg, Germany, 37Clinical Gerontology,
University of Cambridge, UK, 38Cancer Epidemiology
Unit, University of Oxford, Oxford, UK, 39Department
of Community Medicine, University of Tromsø,
Tromsø, Norway, 40Department of Surgery, Malmo¨
University Hospital, Malmo¨, Sweden, 41Department
of Epidemiology & Public Health, Imperial College
London, UK, 42Epidemiology Department, Regional
Health Authority, Murcia, Spain, 43CIBER en Epide-
miologı´a y Salud Pu´blica (CIBERESP), Spain,
44Department of Cardiology and Department of Clin-
ical Epidemiology, Aarhus University Hospital, Aal-
borg, Denmark, 45Molecular and Nutritional
Epidemiology Unit, CSPO-Scientific Institute of Tus-
cany, Florence, Italy, 46Dipartimento di Medicina Clin-
ica e Sperimentale, Universita` di Napoli, Italy, 47Julius
Center for Health Sciences and Primary Care, Univer-
sity Medical Center Utrecht, Utrecht, The Netherlands,
48Health Information Unit, Public Health and Health
Planning Directorate, Asturias, Spain, 49International
Agency for Research on Cancer (IARC-WHO), Lyon,
France, 50Escuela Andaluza de Salud Publica, Gran-
ada, Spain, 51Danish Cancer Society, Institute of
Cancer Epidemiology, Copenhagen, Denmark,
52Department of Hygiene and Epidemiology, School
of Medicine, University of Athens, Greece, 53Hellenic
Health Foundation, Athens, Greece, 54Cancer Registry,
Azienda Ospedaliera ‘‘Civile M.P.Arezzo’’, Ragusa,
Italy, 55University of Torino, Torino, Italy, 56Estonian
Genome Project of University of Tartu, Tartu, Estonia,
57National Institute for Welfare and Health, Helsinki,
Finland, 58Institute for Molecular Medicine Finland
FIMM, University of Helsinki and National Public
Health Institute, Helsinki, Finland, 59Generation Scot-
land, University of Edinburgh, Molecular Medicine
Centre, Western, General Hospital, Edinburgh, UK,
60Biomedical Research Institute, University of
Dundee, UK, 61Latvian Biomedical Research and
Study Center, Riga, Latvia, 62Epidemiology and Preven-
tion Division, Research Center for Cancer Prevention
and Screening, National Cancer Center, Tokyo, Japan,
63GSF National Research Center for Environment and
Health, Institute of Epidemiology, Neuherberg, Ger-
many, 64Institute of Epidemiology, Helmholtz Zentrum
Mu¨nchen, Ludwig-Maximilians-Universita¨t, Munich,
THE DATASHAPER APPROACH AND RETROSPECTIVE HARMONIZATION 1327






Germany, 65Institute of Medical Informatics, Biometry
and Epidemiology, Ludwig-Maximilians-Universita¨t,
Munich, Germany, 66Klinikum Grosshadern, Ludwig-
Maximilians-Universita¨t Mu¨nchen, Munich, Ger-
many, 67Clinical Trial Service Unit & Epidemiological
Studies Unit (CTSU), University of Oxford, Oxford,
UK, 68The Chinese Academy of Medical Sciences, Bei-
jing, China, 69School of Public Health, Peking Univer-
sity, Beijing, China, 70Research Program on Genes,
Environment and Health, Kaiser Permanente Division
of Research, Oakland, CA, USA, 71Department of Pre-
ventive Medicine, Seoul National University College of
Medicine, Seoul, Korea, 72Cancer Research Institute,
Seoul National University Institute of Health Policy
and Management, Seoul National University, Seoul,
Korea, 73Department of Medical Epidemiology and
Biostatistics, Karolinska Institutet, Stockholm,
Sweden, 74LifeLines, University Medical Center Gro-
ningen, University of Groningen, Groningen, The
Netherlands, 75Department of Endocrinology and
Metabolism, University Medical Center Groningen,
University of Groningen, Groningen, The Netherlands,
76Department of Clinical Sciences, Malmo¨ University
Hospital, Lund University, Malmo¨, Sweden, 77Center
for Genetic Epidemiology, University of Melbourne,
Melbourne, Australia, 78Department of Epidemiology,
The University of Texas M.D. Anderson Cancer
Center, Houston, Texas, USA, 79Laboratory of Genetic
and Environmental Epidemiology, Research Labora-
tories, ‘‘John Paul II’’ Center for High Technology
Research and Education in Biomedical Sciences, Cath-
olic University, Campobasso, Italy, 80Montreal Heart
Institute, Universite´ de Montre´al, Montre´al, Quebec,
Canada, 81Nutritional Epidemiology Branch, Division
of Cancer Epidemiology and Genetics, National
Cancer Institute, Rockville, MD, USA, 82The Center
for Genetic Medicine, Robert H. Lurie Comprehensive
Cancer Center, Northwestern University, Chicago, IL,
USA, 83Centre for Longitudinal Studies, Institute of
Education, University of London, London, UK,
84Banco Nacional de ADN, Universidad de Salamanca,
Fundacion Genoma Espan˜a, Consejerı´a de Sanidad de
la Junta de Castilla y Leo´n, Spain, 85Division of Health
and Nutrition Examination Surveys, National Center
for Health Statistics, Centers for Disease Control and
Prevention, Hyattsville, MD, USA, 86Department of
Public Health, Norwegian University of Science and
Technology, Trondheim, Norway, 87UMR U 557
INSERM, U 1125 INRA, CNAM, Universite´ Paris 13,
Bobigny, France, 88De´partement de Sante´ Publique,
Hoˆpital Avicenne, Bobigny, France, 89Department of
Epidemiology and Public Health, Centre for Molecular
Epidemiology, Yong Loo Lin School of Medicine,
National University of Singapore, Singapore,
90Epidemiology Branch, National Institute of Environ-
mental Health Sciences, Research Triangle Park, NC
27709, USA, 91Clinical Trial Service Unit and Epide-
miological Studies Unit, University of Oxford, Oxford,
UK, 92UK Biobank, Units 1&2 Spectrum Way, Ads-
wood, Stockport, Cheshire, UK, 93Centre for Epide-
miology and Biostatistics, Nutritional Epidemiology
Group, University of Leeds, Leeds, UK, 94Cancer
Prevention Program, Fred Hutchinson Cancer
Research Center, Seattle, WA, USA, 95Genetic Epide-
miology and Biostatistics Platform, Ontario Institute
for Cancer Research, Toronto, Ontario, Canada,
96Samuel Lunenfeld Research Institute, University
of Toronto, Toronto, Canada, 97Public Population
Project in Genomics (P3G), Montreal, QC, Canada,
98Department of Health Sciences and Department of
Genetics, University of Leicester, Leicester, UK
1328 INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
 at Rijksuniversiteit Groningen on December 20, 2011
http://ije.oxfordjournals.org/
D
ow
nloaded from
 
